ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,156Medicare Part D Prescriptions Filled, Including Refills

Rank: 225 out of 1171

$547K Total Retail Price of All Prescriptions

Rank: 186 out of 1171

454 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,673 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LISINOPRIL 470 389 1 3
CARVEDILOL 330 279 2 20
ATORVASTATIN CALCIUM 316 260 3 10
AMLODIPINE BESYLATE 281 260 4 2
PRAVASTATIN SODIUM 261 247 5 13
SIMVASTATIN 253 208 6 1
METFORMIN HCL 245 206 7 7
LEVOTHYROXINE SODIUM 244 184 8 4
OMEPRAZOLE 186 160 9 5
LOSARTAN POTASSIUM 185 167 10 14
METOPROLOL TARTRATE 173 148 11 11
CITALOPRAM HBR 166 139 12 22
WARFARIN SODIUM 148 137 13 12
HYDROCHLOROTHIAZIDE 145 119 14 9
TRAMADOL HCL 128 85 15 18
CRESTOR 128 103 15 27
NEXIUM 126 96 17 25
FUROSEMIDE 126 113 17 6
HYDROCODONE-ACETAMINOPHEN 105 79 S3 19 8
ZOLPIDEM TARTRATE 103 61 20 21
ALLOPURINOL 88 64 21 31
TAMSULOSIN HCL 87 75 22 28
HYDRALAZINE HCL 85 85 23 60
GABAPENTIN 82 38 24 16
RAMIPRIL 75 53 25 85
ROPINIROLE HCL 71 60 26 119
ESCITALOPRAM OXALATE 67 55 27 69
PREDNISONE 67 63 27 39
ATENOLOL 60 56 29 15
AMLODIPINE BESYLATE-BENAZEPRIL 60 48 29 70
GLIMEPIRIDE 59 47 31 34
DONEPEZIL HCL 58 58 32 24
PANTOPRAZOLE SODIUM 55 54 33 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 52 33 26
FINASTERIDE 54 43 35 88
NIFEDIPINE ER 54 54 35 114
AMITRIPTYLINE HCL 54 30 R 35 74
LIPITOR 53 44 38 92
FLUTICASONE PROPIONATE 53 49 38 30
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 40 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.